drug
Iheezo
Marketedupdated 3mo agoby $HROW HARROW, INC.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Iheezo
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 15, 2038
~12.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- May 14, 2039formulationUS 11969403
- Sep 15, 2038formulationUS 10792271
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that